13F Pro Quality Score

31.4/100

Rank #2,316 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

33.5/100

Profitability

18.6/100

Balance Sheet

19.7/100

Earnings Quality

30.0/100

Free Cash Flow

27.4/100

Institutional Flow

66.5/100

Revenue Scale

46.2/100

Dilution Risk

42.4/100

VREX Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Varex Imaging Corp (VREX), a Technology sector company. 13F Pro's AI-powered ranking engine scores VREX at 31.4/100 on a 32-signal composite quality model, placing it at rank #2,316 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include profitability (18.6) and balance sheet strength (19.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 42.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Varex Imaging Corp reports quarterly revenue of $216.0M, net income of $-8.1M, free cash flow of $-7.7M. Top institutional holders of VREX by reported 13-F value include PZENA INVESTMENT MANAGEMENT, BlackRock,, Allspring Global Investments Holdings,, based on the most recent SEC filings. VREX trades on the Nasdaq exchange and files with the SEC under CIK 1681622. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate VREX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Varex Imaging Corp directly from SEC EDGAR.

Fun facts about Varex Imaging Corp

Quirks, history, and lore behind VREX — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. technology company · small-cap · listed on Nasdaq · headquartered in Utah.
  • 2
    The Numbers
    Annual revenue in the range of $800 million, with customers spread across medical, industrial, and security markets worldwide.
  • 3
    The History
    Spun off from Varian Medical Systems in 2017 as an independent public company, inheriting decades of expertise in a very specialized corner of radiation technology.
  • 4
    The Secret
    It doesn't treat patients — it makes the X-ray tubes and detectors that go inside the machines that do, supplying the components other manufacturers quietly depend on.
  • 5
    The Lore
    Its components are embedded in equipment used for airport baggage scanning, cancer radiotherapy, and industrial inspection — you've almost certainly passed through one of its detectors without knowing it.
  • 6
    The Giveaway
    The world's largest independent supplier of X-ray imaging components, its very name is a portmanteau of its parent, Varian, and the word for energy radiation — Varex.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$216.0M

Net Income

Q2 2026

$-8.1M

Free Cash Flow

Q2 2026

$-7.7M

D/E Ratio

Q2 2026

0.77

Get alerted when VREX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Varex Imaging Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of VREX

Put VREX on your watchlist

Track score changes the day Varex Imaging Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is VREX a good stock to buy?

13F Pro's AI-powered analysis of Varex Imaging Corp (VREX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for VREX are available on the VREX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own VREX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling VREX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Varex Imaging Corp's investment landscape.